These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 15021823)

  • 1. Targeted bone marrow radioablation with 153Samarium-lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness.
    Inverardi L; Linetsky E; Pileggi A; Molano RD; Serafini A; Paganelli G; Ricordi C
    Transplantation; 2004 Mar; 77(5):647-55. PubMed ID: 15021823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
    Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
    Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Sachs DH; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model.
    Ishii R; Hirai T; Miyairi S; Omoto K; Okumi M; Ishii Y; Tanabe K
    Am J Transplant; 2018 Feb; 18(2):328-340. PubMed ID: 28766890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning.
    Durham MM; Bingaman AW; Adams AB; Ha J; Waitze SY; Pearson TC; Larsen CP
    J Immunol; 2000 Jul; 165(1):1-4. PubMed ID: 10861026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning.
    Bingaman AW; Waitze SY; Alexander DZ; Cho HR; Lin A; Tucker-Burden C; Cowan SR; Pearson TC; Larsen CP
    Transplantation; 2000 Jun; 69(12):2491-6. PubMed ID: 10910268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal tolerance induction: relationship between cell dose, marrow T-cells, chimerism, and tolerance.
    Chen JC; Chang ML; Huang SF; Chang PY; Muench MO; Fu RH; Ou LS; Kuo ML
    Cell Transplant; 2008; 17(5):495-506. PubMed ID: 18714669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
    Wekerle T; Sayegh MH; Ito H; Hill J; Chandraker A; Pearson DA; Swenson KG; Zhao G; Sykes M
    Transplantation; 1999 Nov; 68(9):1348-55. PubMed ID: 10573075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.
    Forman D; Tian C; Iacomini J
    Mol Ther; 2005 Aug; 12(2):353-9. PubMed ID: 15939670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of tolerance induction through prenatal marrow transplantation: the requirement for a threshold level of chimerism to establish rather than maintain postnatal skin tolerance.
    Chen JC; Kuo ML; Ou LS; Chang PY; Muench MO; Shen CR; Chang HL; Yu HY; Fu RH
    Cell Transplant; 2010; 19(12):1609-22. PubMed ID: 20719075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning.
    Blaha P; Bigenzahn S; Koporc Z; Sykes M; Muehlbacher F; Wekerle T
    Transplantation; 2005 Jul; 80(2):237-43. PubMed ID: 16041269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.
    Xu H; Zhu Z; Huang Y; Bozulic LD; Hussain LR; Yan J; Ildstad ST
    Transplantation; 2012 Mar; 93(5):469-76. PubMed ID: 22228418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.
    Chan WF; Razavy H; Luo B; Shapiro AM; Anderson CC
    J Immunol; 2008 Apr; 180(8):5177-86. PubMed ID: 18390699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.